Cannabinoid Encyclopedia

Cannabinoid Comparison

CBD vs CBDV: What Is the Difference?

A source-led comparison of CBD and CBDV, their distinct research records, and product identity limits.

The short answer

What should you know first?

CBD and CBDV are different cannabinoids. CBD has broader research coverage; CBDV has a separate and smaller evidence record.

Key differences

Compare the right things

Key distinction

Identity

The compounds are distinct.

Key distinction

Evidence

Their evidence depth differs.

Key distinction

Transfer

A result for CBD is not automatically a CBDV result.

What studies reported

Results worth understanding

These findings belong to the named compound or product, dose, route, population, and outcome. They are not one result for every cannabinoid product or person. Open the PubMed links to inspect the original records.

CBD evidence record

CBD has randomized seizure-trial evidence

A randomized placebo-controlled trial of prescription CBD in Dravet syndrome reported a greater reduction in convulsive-seizure frequency than placebo. That evidence belongs to CBD and the trial population. PubMed 28538134

CBDV phase 1 study

CBDV was studied in girls with Rett syndrome

A phase 1 trial evaluated CBDV treatment in girls with Rett syndrome. Its early clinical design should not be treated as the same evidence depth as CBD's controlled seizure trials. PubMed 35364618

CBDV single-dose study

CBDV was studied with functional-connectivity measurements

A randomized single-dose study examined CBDV and striatal functional connectivity in adults with and without autism spectrum disorder. Imaging measures are not clinical efficacy endpoints. PubMed 34210360

CBDV animal study

CBDV showed anticonvulsant activity in mouse and rat models

A preclinical study reported anticonvulsant activity for CBDV in mouse and rat seizure models. This is not a human seizure outcome. PubMed 22970845

Research context

Read the evidence in context

CBD and CBDV are different compounds with different records

CBD and CBDV have similar names but are distinct cannabinoids. CBD has a broader human research and safety record. CBDV has a smaller record that includes early clinical and neurobiology studies alongside a substantial preclinical literature. A CBD result should not be used as a shortcut for a CBDV result.

Read next CBD Open CBD evidence and safety context. Read next CBDV Open the distinct CBDV evidence record.

CBDV clinical work is still narrow

Human CBDV studies in the current evidence profile include a phase 1 Rett syndrome trial and single-dose studies that measured brain imaging or spectroscopy outcomes in adults with and without autism spectrum disorder. These are meaningful research steps, but they are not a broad efficacy record across consumer questions.

Read next CBDV evidence profile Read the study types and their limits.

Animal seizure studies cannot establish a human seizure outcome

CBDV has been studied in mouse and rat seizure models, where researchers reported anticonvulsant-related effects. Animal research can point to mechanisms or justify a human trial, but it does not establish a clinical result, a consumer dose, or a substitute for the defined prescription-CBD studies used in seizure research.

Read next CBD seizure research Keep CBD's clinical seizure record distinct. Read next Preclinical evidence Read how animal evidence is classified.

A comparison needs the full product name

CBDV may appear in a mixed extract or a product with other cannabinoids. That does not make the product a CBDV-only intervention. The route, amount, co-occurring cannabinoids, and the study outcome all remain part of what the evidence can support.

Read next Formulation Keep product details connected to the claim. Read next How to read a COA Inspect batch identity separately from outcome evidence.

Important limits

What can make the answer change?

  1. 1

    Do not use the terms interchangeably.

  2. 2

    Do not transfer outcome claims between compounds.

  3. 3

    Do not ignore product identity.

Common questions

Questions people ask

Does CBDV have human research?

Yes, but the current record is narrower and includes phase 1 and single-dose neurobiology studies. It should not be presented as a broad clinical outcome record. PubMed 35364618 PubMed 34210360 PubMed 31748505

Has CBDV been studied for seizures?

CBDV has animal seizure studies and early clinical work. That is different from the randomized prescription-CBD trials in specific epilepsy populations. PubMed 22970845 PubMed 35364618 PubMed 28538134

{"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"Is CBDV the same as CBD?","acceptedAnswer":{"@type":"Answer","text":"No. CBDV and CBD are distinct cannabinoids with separate research records."}},{"@type":"Question","name":"Does CBDV have human research?","acceptedAnswer":{"@type":"Answer","text":"Yes, but the current record is narrower and includes phase 1 and single-dose neurobiology studies. It should not be presented as a broad clinical outcome record."}},{"@type":"Question","name":"Has CBDV been studied for seizures?","acceptedAnswer":{"@type":"Answer","text":"CBDV has animal seizure studies and early clinical work. That is different from the randomized prescription-CBD trials in specific epilepsy populations."}},{"@type":"Question","name":"Can CBD results be applied to CBDV?","acceptedAnswer":{"@type":"Answer","text":"No. Similar names do not make two compounds interchangeable research exposures."}}]}